Michel Detheux
CIK 1816196 · Chief Executive Officer · last filed 2025-08-29
Michel Detheux is a Chief Executive Officer who has filed 26 SEC Form 4 insider transactions across 2 companies since 2020. The most recent filing, for ITOS, was dated Aug 29, 2025. Across all open-market trades the lifetime net is −$10.0M, making them a net seller over the disclosed history.
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
$0
2
26
-$10.04M
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| iTeos Therapeutics, Inc. (ITOS) Delisted | Chief Executive Officer | 0 | $10.15 | $0 | -$10.04M | 25 | 2025-08-29 |
| VOR | Director | — | $14.36 | — | $0 | 1 | 2025-07-18 |
Recent Filings
26 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2025-08-29 | iTeos Therapeutics, Inc. (ITOS) Delisted | Mixed | −247,930 | $0 | EDGAR |
| 2025-07-18 | VOR | Grant (A) | — | $0 | EDGAR |
| 2025-06-11 | iTeos Therapeutics, Inc. (ITOS) Delisted | Mixed | +112,027 | -$116.9K | EDGAR |
| 2025-06-06 | iTeos Therapeutics, Inc. (ITOS) Delisted | Mixed | — | -$918.1K | EDGAR |
| 2025-03-11 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | +77,000 | $0 | EDGAR |
| 2024-08-09 | iTeos Therapeutics, Inc. (ITOS) Delisted | Gift (G) | — | $0 | EDGAR |
| 2024-03-08 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | — | $0 | EDGAR |
| 2023-12-07 | iTeos Therapeutics, Inc. (ITOS) Delisted | Grant (A) | +30,000 | $0 | EDGAR |
| 2023-03-10 | iTeos Therapeutics, Inc. (ITOS) Delisted | Mixed | — | $0 | EDGAR |
| 2022-04-19 | iTeos Therapeutics, Inc. (ITOS) Delisted | Mixed | — | -$317.9K | EDGAR |